Joeri Mul1, Martine van Grotel2, Enrica Seravalli3, Mirjam E Bosman3, Harm van Tinteren2, Prakriti Roy2, Raquel Dávila Fajardo1, Godelieve A M Tytgat2, Annelies M C Mavinkurve-Groothuis2, Cornelis P van de Ven2, Marc H W A Wijnen2, Ronald R de Krijger4, Annemieke S Littooij5, Marry M van den Heuvel-Eibrink2, Geert O Janssens6. 1. Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Department of Radiation Oncology, University Medical Center Utrecht, The Netherlands. 2. Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. 3. Department of Radiation Oncology, University Medical Center Utrecht, The Netherlands. 4. Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Department of Pathology, University Medical Center Utrecht, The Netherlands. 5. Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Department of Radiology, University Medical Center Utrecht, The Netherlands. 6. Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands; Department of Radiation Oncology, University Medical Center Utrecht, The Netherlands. Electronic address: G.O.R.Janssens@umcutrecht.nl.
Abstract
BACKGROUND AND PURPOSE: In pediatric renal tumors, conventional two opposing photon beams have been used to cover the postoperative flank target volume for decades. This single center study describes the locoregional outcome using highly conformal flank target volumes adjusted for postoperative changes and intra-fraction motion combined with Volumetric-Modulated Arc Therapy (VMAT). MATERIALS AND METHODS: Between 01-2015 and 12-2019, 36/161 newly diagnosed patients with renal tumors underwent flank only irradiation (n = 30) or flank + whole lung irradiation (n = 6) using highly conformal target volumes in line with the SIOP-RTSG consensus statement. VMAT consisted of full-arc 10MV photon beams optimized for constraints of the organs at risk. In case of locoregional relapses, image co-registration and dose reconstruction was performed. Each relapse was classified as either 'infield' (V95%relapse: ≥99.0%), 'marginal' (V95%relapse: 20.0-98.9%) or 'outfield' (V95%relapse: 0-19.9%). RESULTS: At a median follow-up from diagnosis of 3.1 years (range:0.4-5.7), the estimated 2-year Locoregional Control Rate, Disease-Free Interval and Overall Survival were 94%, 91% and 94%, respectively. Locoregional relapse was observed in two patients. One patient had a combined tumor bed and regional recurrence, classified as infield (V95%relapse: 100%) and outfield (V95%relapse: 1.2%). The second patient had a regional relapse in the inferior vena cava classified as marginal recurrence (V95%relapse: 93%). Relapses would not have been adequately covered by conventional beams. CONCLUSIONS: This single center analysis provides encouraging evidence that excellent locoregional control can be obtained by using highly conformal flank target volumes with VMAT in pediatric renal tumors. The safety of this approach will be validated in a prospective multicenter study.
BACKGROUND AND PURPOSE: In pediatric renal tumors, conventional two opposing photon beams have been used to cover the postoperative flank target volume for decades. This single center study describes the locoregional outcome using highly conformal flank target volumes adjusted for postoperative changes and intra-fraction motion combined with Volumetric-Modulated Arc Therapy (VMAT). MATERIALS AND METHODS: Between 01-2015 and 12-2019, 36/161 newly diagnosed patients with renal tumors underwent flank only irradiation (n = 30) or flank + whole lung irradiation (n = 6) using highly conformal target volumes in line with the SIOP-RTSG consensus statement. VMAT consisted of full-arc 10MV photon beams optimized for constraints of the organs at risk. In case of locoregional relapses, image co-registration and dose reconstruction was performed. Each relapse was classified as either 'infield' (V95%relapse: ≥99.0%), 'marginal' (V95%relapse: 20.0-98.9%) or 'outfield' (V95%relapse: 0-19.9%). RESULTS: At a median follow-up from diagnosis of 3.1 years (range:0.4-5.7), the estimated 2-year Locoregional Control Rate, Disease-Free Interval and Overall Survival were 94%, 91% and 94%, respectively. Locoregional relapse was observed in two patients. One patient had a combined tumor bed and regional recurrence, classified as infield (V95%relapse: 100%) and outfield (V95%relapse: 1.2%). The second patient had a regional relapse in the inferior vena cava classified as marginal recurrence (V95%relapse: 93%). Relapses would not have been adequately covered by conventional beams. CONCLUSIONS: This single center analysis provides encouraging evidence that excellent locoregional control can be obtained by using highly conformal flank target volumes with VMAT in pediatric renal tumors. The safety of this approach will be validated in a prospective multicenter study.
Authors: Joeri Mul; Enrica Seravalli; Mirjam E Bosman; Cornelis P van de Ven; Annemieke S Littooij; Martine van Grotel; Marry M van den Heuvel-Eibrink; Geert O Janssens Journal: Clin Transl Radiat Oncol Date: 2021-05-03
Authors: Prakriti Roy; Sophie E van Peer; Martin M de Witte; Godelieve A M Tytgat; Henrike E Karim-Kos; Martine van Grotel; Cees P van de Ven; Annelies M C Mavinkurve-Groothuis; Johannes H M Merks; Roland P Kuiper; Janna A Hol; Geert O R Janssens; Ronald R de Krijger; Marjolijn C J Jongmans; Jarno Drost; Alida F W van der Steeg; Annemieke S Littooij; Marc H W A Wijnen; Harm van Tinteren; Marry M van den Heuvel-Eibrink Journal: PLoS One Date: 2022-01-13 Impact factor: 3.240
Authors: Christiaan A J Oudmaijer; Winnie M C van den Boogaard; Daphne S J Komninos; Emma J Verwaaijen; Hanneke M van Santen; Marc R Lilien; Jan H J Hoeijmakers; Marc H W Wijnen; Marry M van den Heuvel-Eibrink; Wilbert P Vermeij Journal: Front Pediatr Date: 2022-01-27 Impact factor: 3.418
Authors: Sophie E van Peer; Janna A Hol; Alida F W van der Steeg; Martine van Grotel; Godelieve A M Tytgat; Annelies M C Mavinkurve-Groothuis; Geert O R Janssens; Annemieke S Littooij; Ronald R de Krijger; Marjolijn C J Jongmans; Marc R Lilien; Jarno Drost; Roland P Kuiper; Harm van Tinteren; Marc H W A Wijnen; Marry M van den Heuvel-Eibrink Journal: J Clin Med Date: 2021-11-26 Impact factor: 4.241
Authors: M E Madeleine van der Perk; Nicholas G Cost; Annelies M E Bos; Robert Brannigan; Tanzina Chowdhury; Andrew M Davidoff; Najat C Daw; Jeffrey S Dome; Peter Ehrlich; Norbert Graf; James Geller; John Kalapurakal; Kathleen Kieran; Marcus Malek; Mary F McAleer; Elizabeth Mullen; Luke Pater; Angela Polanco; Rodrigo Romao; Amanda F Saltzman; Amy L Walz; Andrew D Woods; Marry M van den Heuvel-Eibrink; Conrad V Fernandez Journal: Int J Cancer Date: 2022-05-11 Impact factor: 7.316